Advertisement

Charcot-Marie-Tooth disease type 1 (CMT1) and hereditary neuropathy with liability to pressure palsy (HNPP)

  • E. Nelis
  • P. De Jonghe
  • V. Timmerman
Chapter
  • 648 Downloads

Keywords

Hereditary Neuropathy Myelin Protein Zero PMP22 Gene Peripheral Myelin Protein Pressure Palsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ammar N, Nelis E, Merlini L, Barisic N, Amouri R, Ceuterick C, Martin JJ, Timmerman V, Hentati F, De Jonghe P (2003) Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease. Neuromusc Disord 13:720–728PubMedGoogle Scholar
  2. 2.
    Andersson PB, Yuen E, Parko K, So YT (2000) Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. Neurology 54:40–44PubMedGoogle Scholar
  3. 3.
    Angelicheva D, Turnev I, Dye D, Chandler D, Thomas PK, Kalaydjieva L (1999) Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome: a novel developmental disorder in Gypsies maps to 18qter. Eur J Hum Genet 7:560–566PubMedCrossRefGoogle Scholar
  4. 4.
    Arbuthnott ER, Boyd IA, Kalu KU (1980) Ultrastructural dimensions of myelinated peripheral nerve fibres in the cat and their relation to conduction velocity. J Physiol 308:125–157PubMedGoogle Scholar
  5. 5.
    Auer-Grumbach M, Strasser-Fuchs S, Wagner K, Korner E, Fazekas F (1998) Roussy-Levy syndrome is a phenotypic variant of Charcot-Marie-Tooth syndrome IA associated with a duplication on chromosome 17p11.2. J Neurol Sci 154:72–75PubMedCrossRefGoogle Scholar
  6. 6.
    Azzedine H, Bolino A, Taieb T, Birouk N, Di Duca M, Bouhouche A, Benamou S, Mrabet A, Hammadouche T, Chkili T, Gouider R, Ravazzolo R, Brice A, Laporte J, LeGuern E (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet 72:1141–1153PubMedCrossRefGoogle Scholar
  7. 7.
    Barhoumi C, Amouri R, Ben Hamida C, Ben Hamida M, Machghoul S, Gueddiche M, Hentati F (2001) Linkage of a new locus for autosomal recessive axonal form of Charcot-Marie-Tooth disease to chromosome 8q21.3. Neuromusc Disord 11:27–34PubMedGoogle Scholar
  8. 8.
    Baxter RV, Ben Othmane K, Rochelle JM, Stajich JE, Hulette C, Dew-Knight S, Hentati F, Ben Hamida M, Bel S, Stenger JE, Gilbert JR, Pericak-Vance M, Vance JM (2002) Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 30:21–22PubMedCrossRefGoogle Scholar
  9. 9.
    Behse F, Buchthal F, Carlsen F, Knappeis GG (1972) Hereditary neuropathy with liability to pressure palsies. Electrophysiological and histopathological aspects. Brain 95:777–794PubMedGoogle Scholar
  10. 10.
    Ben Othmane K, Hentati F, Lennon F, Ben Hamida C, Blel S, Roses AD, Pericak-Vance MA, Ben Hamida M, Vance JM (1993) Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum Mol Genet 2:1625–1628PubMedGoogle Scholar
  11. 11.
    Ben Othmane K, Johnson E, Menold M, Graham FL, Hamida MB, Hasegawa O, Rogala AD, Ohnishi A, Pericak-Vance M, Hentati F, Vance JM (1999) Identification of a new locus for autosomal recessive Charcot-Marie-Tooth disease with focally folded myelin on chromosome 11p15. Genomics 62:344–349Google Scholar
  12. 12.
    Bennett CL, Shirk AJ, Huynh HM et al (2004) SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve. Ann Neurol 55:713–720PubMedCrossRefGoogle Scholar
  13. 13.
    Berciano J, Garcia A, Combarros O (2003) Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication. Muscle Nerve 27:34–39PubMedCrossRefGoogle Scholar
  14. 14.
    Berciano J, Garcia CA, Calleja J, Combarros O (2000) Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease 1A duplication. Neuromusc Disord 10:419–424PubMedGoogle Scholar
  15. 15.
    Berger P, Young P, Suter U (2002) Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics 4:1–15PubMedCrossRefGoogle Scholar
  16. 16.
    Bird TD, Ott J, Giblett ER (1982) Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet 34:388–394PubMedGoogle Scholar
  17. 17.
    Birouk N, Gouider R, LeGuern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P (1997) Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813–823PubMedCrossRefGoogle Scholar
  18. 18.
    Blair IP, Nash J, Gordon MJ, Nicholson GA (1996) Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: First report of a de novo duplication with a maternal origin. Am J Hum Genet 58:472–476PubMedGoogle Scholar
  19. 19.
    Boerkoel CF, Takashima H, Bacino CA, Daentl D, Lupski JR (2001) EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy. Neurogenetics 3:153–157PubMedCrossRefGoogle Scholar
  20. 20.
    Boerkoel CF, Takashima H, Garcia CA, Olney RK, Johnson J, Berry K, Russo P, Kennedy S, Teebi AS, Scavina M, Williams LL, Mancias P, Butler IJ, Krajewski K, Shy M, Lupski JR (2002) Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 51:190–201PubMedCrossRefGoogle Scholar
  21. 21.
    Boerkoel CF, Takashima H, Nakagawa M, Izumo S, Armstrong D, Butler I, Mancias P, Papasozomenos SC, Stern LZ, Lupski JR (2003) CMT4A: identification of a Hispanic GDAP1 founder mutation. Ann Neurol 53:400–405PubMedCrossRefGoogle Scholar
  22. 22.
    Boerkoel CF, Takashima H, Stankiewicz P, Garcia CA, Leber SM, Rhee-Morris L, Lupski JR (2001) Periaxin mutations causes recessive Dejerine-Sottas Neuropathy. Am J Hum Genet 68:325–333PubMedCrossRefGoogle Scholar
  23. 23.
    Bolino A, Brancolini V, Bono F, Bruni A, Gambardella A, Romeo G, Quattrone A, Devoto M (1996) Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet 5:1051–1054PubMedCrossRefGoogle Scholar
  24. 24.
    Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM, Christodoulou K, Hausmanowa-Petrusewicz I, Mandich P, Schenone A, Gambardella A, Bono F, Quattrone A, Devoto M, Monaco AP (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25:17–19PubMedGoogle Scholar
  25. 25.
    Brancolini C, Marzinotto S, Edomi P, Agostoni E, Fiorentini C, Muller HW Schneider C (1999) Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol Biol Cell 10:2441–2459PubMedGoogle Scholar
  26. 26.
    Ceuterick-de Groote C, De Jonghe P, Timmerman V, Van Goethem G, Löfgren A, Ceulemans B, Van Broeckhoven C, Martin JJ (2001) Infantile demyelinating neuropathy associated with a de novo point mutation on Ser72 in PMP22 and basal lamina onion bulbs in skin biopsy. Pathol Res Pract 197:193–198PubMedGoogle Scholar
  27. 27.
    Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Distsche CM, Bird TD (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143–151PubMedCrossRefGoogle Scholar
  28. 28.
    Chapon F, Latour P, Diraison P, Schaeffer S, Vandenberghe A (1999) Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry 66:779–782PubMedCrossRefGoogle Scholar
  29. 29.
    Charcot J-M, Marie P (1886) Sur une forme particulière d’atrophie musculaire progressive, souvent familiale, débutant par les pieds et les jambes et atteignant plus tard les mains. Rev Méd 6:97–138Google Scholar
  30. 30.
    Chavrier P, Janssen-Timmen U, Mattei MG, Zerial M, Bravo R, Charnay P (1989) Structure, chromosome location, and expression of the mouse zinc finger gene Krox-20: multiple gene products and coregulation with the proto-oncogene c-fos. Mol Cell Biol 9:787–797PubMedGoogle Scholar
  31. 31.
    Cuesta A, Pedrola L, Sevilla T, Garcia-Planells J, Chumillas MJ, Mayordomo F, LeGuern E, Marin I, Vilchez JJ, Palau F (2002) The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 30:22–25PubMedCrossRefGoogle Scholar
  32. 32.
    Cui X, De V, I, Slany R, Miyamoto A, Firestein R, Cleary ML (1998) Association of SET domain and myotubularin-related proteins modulates growth control. Nat Genet 18:331–337PubMedCrossRefGoogle Scholar
  33. 33.
    D’Urso D, Ehrhardt P, Muller HW (1999) Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J Neurosci 19:3396–3403PubMedGoogle Scholar
  34. 34.
    De Jonghe P (1998) The inherited neuropathies of the peripheral nervous system in the DNA era: genotype-phenotype correlations. University of AntwerpenGoogle Scholar
  35. 35.
    De Jonghe P, Mersiyanova IV, Nelis E, Del Favero J, Martin J-J, Van Broeckhoven C, Evgrafov OV, Timmerman V (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol 49:245–249PubMedGoogle Scholar
  36. 36.
    De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Löfgren A, Vercruyssen A, Verellen C, Van Maldergem L, Martin J-J, Van Broeckhoven C (1999) The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 122:281–290PubMedGoogle Scholar
  37. 37.
    Dejerine J, Sottas J (1893) Sur la névrite interstitielle, hypertrophique et progressive de l’enfance. CR Soc Biol (Paris) 45:63–96Google Scholar
  38. 38.
    Delague V, Bareil C, Tuffery S, Bouvagnet P, Chouery E, Koussa S, Maisonobe T, Loiselet J, Megarbane A, Claustres M (2000) Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate gene. Am J Hum Genet 67:236–243PubMedCrossRefGoogle Scholar
  39. 39.
    Dickson KM, Bergeron JJ, Shames I, Colby J, Nguyen DT, Chevet E, Thomas DY, Snipes GJ (2002) Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for “gain-of-function” ER diseases. Proc Natl Acad Sci USA 99:9852–9857PubMedCrossRefGoogle Scholar
  40. 40.
    Ding Y, Brunden KR (1994) The cytoplasmic domain of myelin glycoprotein P0 interacts with the negatively charged phospholipid bilayers. J Biol Chem 269:10764–10770PubMedGoogle Scholar
  41. 41.
    Ekici AB, Oezbey S, Fuchs C, Nelis E, Van Broeckhoven C, Schachner M, Rautenstrauss B (2002) Tracing Myelin Protein Zero (P0) in vivo by construction of P0-GFP fusion proteins. BMC Cell Biol 3:29PubMedCrossRefGoogle Scholar
  42. 42.
    Fabretti E, Edomi P, Brancolini C, Schneider C (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev 9:1846–1856Google Scholar
  43. 43.
    Friede RL, Samorajski T (1970) Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat Rec 167:379–387PubMedCrossRefGoogle Scholar
  44. 44.
    Gabreels-Festen AA (2002) Dejerine-Sottas syndrome grown to maturity: overview of genetic and morphological heterogeneity and follow-up of 25 patients. J Anat 200:341–356PubMedCrossRefGoogle Scholar
  45. 45.
    Gabreëls-Festen AA, Gabreels FJ, Joosten EM, Vingerhoets HM, Renier WO (1992) Hereditary neuropathy with liability to pressure palsies in childhood. Neuropediatrics 23:138–143PubMedGoogle Scholar
  46. 46.
    Gabreëls-Festen AA, Joosten EM, Gabreels FJ, Stegeman DF, Vos AJ, Busch HF (1990) Congenital demyelinating motor and sensory neuropathy with focally folded myelin sheaths. Brain 113(Pt 6):1629–1643PubMedGoogle Scholar
  47. 47.
    Gabreëls-Festen AA, van Beersum S, Eshuis L, LeGuern E, Gabreels F, van Engelen B, Mariman E (1999) Study on the gene and phenotypic characterisation of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33 [see comments]. J Neurol Neurosurg Psychiatry 66:569–574PubMedGoogle Scholar
  48. 48.
    Gabreëls-Festen AAWM, Gabreëls FJM, Jennekens FGI, Joosten EM, Janssen-van Kempen TW (1992) Autosomal recessive form of hereditary motor and sensory neuropathy type I. Neurology 42:1755–1761PubMedGoogle Scholar
  49. 49.
    Gabreëls-Festen AAWM, Hoogendijk JE, Meijerink PHS, Gabreëls FJM, Bolhuis PA, van Beersum SEC, Kulkens T, Nelis E, Jennekens FGI, de Visser M, van Engelen BGM, Van Broeckhoven C, Mariman ECM (1996) Two divergent types of nerve pathology in patients with different PO mutations in Charcot-Marie-Tooth disease. Neurology 47:761–765PubMedGoogle Scholar
  50. 50.
    Gillespie CS, Sherman DL, Blair GE, Brophy PJ (1994) Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12:497–508PubMedCrossRefGoogle Scholar
  51. 51.
    Guilbot A, Williams A, Ravisé N, Verny C, Brice A, Sherman DL, Brophy PJ, LeGuern E, Delague V, Bareil C, Mégarbané A, Claustres M (2001) A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 10:415–421PubMedCrossRefGoogle Scholar
  52. 52.
    Hantke J, Rogers T, French L, Tournev I, Guergueltcheva V, Urtizberea JA, Colomer J, Corches A, Lupu C, Merlini L, Thomas PK, Kalaydjieva L (2003) Refined mapping of the HMSNR critical gene region — construction of a high-density integrated genetic and physical map. Neuromuscul Disord 13:729–736PubMedGoogle Scholar
  53. 53.
    Harati Y, Butler IJ (1985) Congenital hypomyelinating neuropathy. J Neurol Neurosurg Psychiatry 48:1269–1276PubMedGoogle Scholar
  54. 54.
    Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280PubMedGoogle Scholar
  55. 55.
    Hoogendijk JE, Hensels GW, Gabreë;ls-Festen AAWM, Gabreels FJM, Janssen EAM, De Jonghe P, Martin J-J, Van Broeckhoven C, Valentijn LJ, Baas F, de Visser M, Bolhuis PA (1992) De-novo mutation in hereditary motor and sensory neuropathy type 1. Lancet 339:1081–1082PubMedCrossRefGoogle Scholar
  56. 56.
    Houlden H, King RH, Wood NW, Thomas PK, Reilly MM (2001) Mutations in the 5′ region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. Brain 124:907–915PubMedCrossRefGoogle Scholar
  57. 57.
    Hunter M, Bernard R, Freitas E, Boyer A, Morar B, Martins IJ, Tournev I, Jordanova A, Guergelcheva V, Ishpekova B, Kremensky I, Nicholson G, Schlotter B, Lochmüller H, Voit T, Colomer J, Thomas PK, Levy N, Kalaydjieva L (2003) Mutation screening of the N-myc downstream-regulated gene 1 (NDRGI) in patients with Charcot-Marie-Tooth Disease. Hum Mutat 22:129–135PubMedCrossRefGoogle Scholar
  58. 58.
    Ikegami T, Nicholson G, Ikeda H, Ishida A, Johnston H, Wise G, Ouvrier R, Hayasaka K (1996) A novel homozygous mutation of the myelin P0 gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Biochem Biophys Res Commun 222:107–110PubMedCrossRefGoogle Scholar
  59. 59.
    Inoue K, Dewar K, Katsanis N, Reiter IT, Lander ES, Devon KL, Wyman DW Lupski JR, Birren B (2001) The 1.4 Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. Genome Res 11:1018–1033PubMedCrossRefGoogle Scholar
  60. 60.
    Jolliffe CN, Harvey KF, Haines BP, Parasivam G, Kumar S (2000) Identification of multiple proteins expressed in murine embryos as binding partners for the WW domains of the ubiquitin-protein ligase Nedd4. Biochem J 351Pt 3:557–565PubMedGoogle Scholar
  61. 61.
    Jordanova A, De Jonghe P, Boerkoel CF, Takashima H, De Vriendt E, Ceuterick C, Butler I, Mancias P, Papasozomenos SCH, Terespolski D, Potocki L, Brown CW, Shy M, Rita DA, Tournev I, Kremensky I, Lupski JR, Timmerman V (2003) Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 126:590–597PubMedCrossRefGoogle Scholar
  62. 62.
    Joseph LJ, Le Beau MM, Jamieson Jr GA, Acharya S, Shows TB, Rowley JD, Sukhatme VP (1988) Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with “zinc-binding finger” structure. Proc Natl Acad Sci USA 85:7164–7168PubMedGoogle Scholar
  63. 63.
    Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, Blechschmidt K, Angelicheva D, Chandler D, Worsley P, Rosenthal A, King RMK, Thomas PK (2000) N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy — Lom. Am J Hum Genet 67:47–58PubMedCrossRefGoogle Scholar
  64. 64.
    Kalaydjieva L, Hallmayer J, Chandler D, Savov A, Nikolova A, Angelicheva D, King RH, Ishpekova B, Honeyman K, Calafell F, Shmarov A, Petrova J, Turnev I, Hristova A, Moskov M, Stancheva S, Petkova I, Bittles AH, Geogieva V, Middleton L, Thomas PK (1996) Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nature Genet 14:214–217PubMedCrossRefGoogle Scholar
  65. 65.
    Kalaydjieva L, Nikolova A, Turnev I, Petrova J, Hristova A, Ishpekova B, Petkova I, Shmarov A, Stancheva S, Middleton L, Merlini L, Trogu A, Muddle JR, King RH, Thomas PK (1998) Hereditary motor and sensory neuropathy — Lom, a novel demyelinating neuropathy associated with deafness in gypsies. Clinical, electrophysiological and nerve biopsy findings. Brain 121(Pt 3):399–408PubMedGoogle Scholar
  66. 66.
    Kiyosawa H, Chance PF (1996) Primate origin of the CMT1A-REP repeat and analysis of a putative transposon-associated recombinational hotspot. Hum Mol Genet 5:745–753PubMedCrossRefGoogle Scholar
  67. 67.
    Kovach MJ, Lin J-P, Boyadjiev S, Campbell K, Mazzea L, Herman K, Rimer LA, Frank W, Llewellyn B, Jabs EW, Gelber D, Kimonis VE (1999) A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness. Am J Hum Genet 64:1580–1593PubMedCrossRefGoogle Scholar
  68. 68.
    Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME (2000) Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123(Pt 7):1516–1527PubMedGoogle Scholar
  69. 69.
    Kuhn G, Lie A, Wilms S, Müller HW (1993) Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repair. Glia 8:256–264PubMedCrossRefGoogle Scholar
  70. 70.
    Lagier-Tourenne C, Tranebaerg L, Chaigne D, Gribaa M, Dollfus H, Silvestri G, Betard C, Warter JM, Koenig M (2003) Homozygosity mapping of Marinesco-Sjogren syndrome to 5q31. Eur J Hum Genet 11:770–778PubMedCrossRefGoogle Scholar
  71. 71.
    Lambert EH (1960) Neurophysiological techniques useful in the study of neuromuscular disorders. In: Adams RD, Eaton LM, Shy DM (eds) Neuromuscular Disorder (the motor unit and its disorders). Williams & Wilkins, Baltimore, pp 247Google Scholar
  72. 72.
    Lambert EH, Bastron JA, Mulder DW (1958) Conduction velocity of motor fibers of peripheral nerves in peroneal muscular atrophy (Charcot-Marie-Tooth disease). Read at the annual meeting of the American Academy of Neurology, PhiladephiaGoogle Scholar
  73. 73.
    Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, Coy JF, Klauck SM, Poustka A, Dahl N (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13:175–182PubMedCrossRefGoogle Scholar
  74. 74.
    Leal A, Berghoff C, Berghoff M, Del Valle G, Contreras C, Montoya O, Hernandez E, Barrantes R, Schlotzer-Schrehardt U, Neundorfer B, Reis A, Rautenstrauss B, Heuss D (2003) Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family. Neurogenetics 4:191–197PubMedCrossRefGoogle Scholar
  75. 75.
    Lee MK, Cleveland DW (1996) Neuronal intermediate filaments. Annu Rev Neurosci 19:187–217PubMedCrossRefGoogle Scholar
  76. 76.
    Lee MK, Marszalek JR, Cleveland DW (1994) A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 13:975–988PubMedGoogle Scholar
  77. 77.
    LeGuern E, Guilbot A, Kessali M, Ravisé N, Tassin J, Maisonobe T, Grid D, Brice A (1996) Homozygosity mapping of an autosomal recessive form of demyelinating Charcot-Marie-Tooth disease to chromosome 5q23-q33. Hum Mol Genet 5:1685–1688PubMedGoogle Scholar
  78. 78.
    Lemke G, Lamar E, Patterson J (1988) Isolation and analysis of the gene encoding peripheral myelin protein zero. Neuron 1:73–83PubMedGoogle Scholar
  79. 79.
    Liehr T, Rautenstrauss B, Grehl H, Bathke KD, Ekici A, Rauch A, Rott HD (1996) Mosaicism for the Charcot-Marie-Tooth disease type 1A duplication suggests somatic reversion. Hum Genet 98:22–28PubMedCrossRefGoogle Scholar
  80. 80.
    Liu H, Nakagawa T, Kanematsu T, Uchida T, Tsuji S (1999) Isolation of 10 differentially expressed cDNAs in differentiated Neuro2a cells induced through controlled expression of the GD3 synthase gene. J Neurochem 72:1781–1790PubMedCrossRefGoogle Scholar
  81. 81.
    Lopes J, LeGuern E, Gouider R, Tardieu S, Abbas N, Birouk N, Gugenheim M, Bouche P, Agid Y, Brice A, French CMT Collaborative Research Group (1996) Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: New tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. Am J Hum Genet 58:1223–1230PubMedGoogle Scholar
  82. 82.
    Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219–239PubMedCrossRefGoogle Scholar
  83. 83.
    Lupski JR, Wise CA, Kuwano A, Pentao L, Parker J, Glaze D, Ledbetter D, Greenberg F, Patel PI (1992) Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nature Genet 1:29–33PubMedCrossRefGoogle Scholar
  84. 84.
    Mancardi GL, Mandich P, Nassani S, Schenone A, James R, Defferrari R, Bellone E, Giunchedi M, Ajmar F, Abbruzzese M (1995) Progressive sensory-motor polyneuropathy with tomaculous changes is associated to 17p11.2 deletion. J Neurol Sci 131:30–34PubMedCrossRefGoogle Scholar
  85. 85.
    Mancardi GL, Uccelli A, Bellone E, Sghirlanzoni A, Mandich P, Pareyson D, Schenone A, Abbruzzese M (1994) 17p11.2 duplication is a common finding in sporadic cases of Charcot-Marie-Tooth type 1. Eur Neurol 34:135–139PubMedGoogle Scholar
  86. 86.
    Manfioletti G, Ruaro ME, Del Sal G, Philipson L, Schneider C (1990) A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 10:2924–2930PubMedGoogle Scholar
  87. 87.
    Martinotti A, Cariani CT, Melani C, Sozzi G, Spurr NK, Pierotti MA, Colombo MP (1992) Isolation and mapping to 17p12-13 of the human homologous of the murine growth arrest specific Gas-3 gene. Hum Mol Genet 1:331–334PubMedGoogle Scholar
  88. 88.
    Mastaglia FL, Nowak KJ, Stell R, Phillips BA, Edmondston JE, Dorosz SM, Wilton SD, Hallmayer J, Kakulas BA, Laing NG (1999) Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 67:174–179PubMedGoogle Scholar
  89. 89.
    Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, Hanemann CO, Müller HW, Bird TD, White R, Chance PF (1992) Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nature Genet 1:176–179PubMedCrossRefGoogle Scholar
  90. 90.
    McAlpine PJ, Feasby TE, Hahn AF, Komarnicki L, James S, Guy C, Dixon M, Qayyum S, Wright J, Coopland G, Lewis M, Kaita H, Philipps S, Wong P, Koopman W, Cox DW, Yee WC (1990) Localisation of a locus for Charcot-Marie-Tooth neuropathy type Ia (CMTIa) to chromosome 17. Genomics 7:408–415PubMedGoogle Scholar
  91. 91.
    Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin A, Evgrafov OV (2000) A new variant of Charcot-Marie-Tooth disease type 2 (CMT2E) is probably the result of a mutation in the neurofilament light gene. Am J Hum Genet 67:37–46PubMedCrossRefGoogle Scholar
  92. 92.
    Middleton-Price HR, Harding AE, Monteiro C, Berciano J, Malcolm S (1990) Linkage of hereditary motor and sensory neuropathy type I to the pericentromeric region of chromosome 17. Am J Hum Genet 46:92–94PubMedGoogle Scholar
  93. 93.
    Misu K, Yoshihara T, Shikama Y, Awaki E, Yamamoto M, Hattori N, Hirayama M, Takegami T, Nakashima K, Sobue G (2000) An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Va1). J Neurol Neurosurg Psychiatry 69:806–811PubMedCrossRefGoogle Scholar
  94. 94.
    Moriwaki Y, Begum NA, Kobayashi M, Matsumoto M, Toyoshima K, Seya T (2001) Mycobacterium bovis Bacillus Calmette-Guerin and its cell wall complex induce a novel lysosomal membrane protein, SIMPLE, that bridges the missing link between lipopolysaccharide and p53-inducible gene, LITAF(PIG7), and estrogen-inducible gene, EET-1. J Biol Chem 276:23065–23076PubMedCrossRefGoogle Scholar
  95. 95.
    Naef R, Suter U (1999) Impaired intracellular trafficing is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol Disease 6:1–14Google Scholar
  96. 96.
    Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J (2001) Egr2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30:355–368PubMedCrossRefGoogle Scholar
  97. 97.
    Nelis E, Erdem S, Tan E, Löfgren A, Ceuterick C, De Jonghe P, Van Broeckhoven C, Timmerman V, Topaloglu H (2002) A novel homozygous missense mutation in the myotubularin-related protein 2 gene associated with recessive Charcot-Marie-Tooth disease with irregularly folded myelin sheaths. Neuromusc Disord 12:869–873PubMedGoogle Scholar
  98. 98.
    Nelis E, Erdem S, Van Den Bergh PY, Belpaire-Dethiou MC, Ceuterick C, Van G, V, Cuesta A, Pedrola L, Palau F, Gabreels-Festen AA, Verellen C, Tan E, Demirci M, Van Broeckhoven C, De Jonghe P, Topaloglu H, Timmerman V (2002) Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology 59:1865–1872PubMedGoogle Scholar
  99. 99.
    Nelis E, Haites N, Van Broeckhoven C (1999) Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum Mutat 13:11–28PubMedCrossRefGoogle Scholar
  100. 100.
    Nelis E, Holmberg B, Adolfsson R, Holmgren G, Van Broeckhoven C (1997) PMP22 Thr(118)Met: Recessive CMT1 mutation or polymorphism? Nature Genet 15:13–14PubMedCrossRefGoogle Scholar
  101. 101.
    Nelis E, Timmerman V, De Jonghe P, Van Broeckhoven C, Rautenstrauss B (1999) Molecular genetics and biology of inherited peripheral neuropathies: a fast moving field. Neurogenetics 2:137–148PubMedCrossRefGoogle Scholar
  102. 102.
    Nelis E, Van Broeckhoven C, Dejonghe P et al (1996) Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 4:25–33PubMedGoogle Scholar
  103. 103.
    Numakura C, Lin C, Oka N, Akiguchi I, Hayasaka K (2000) Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1. Ann Neurol 47:101–103PubMedCrossRefGoogle Scholar
  104. 104.
    Orstavik K, Skard HM, Young P, Stogbauer F (2001) Brachial plexus involvement as the only expression of hereditary neuropathy with liability to pressure palsies. Muscle Nerve 24:1093–1096PubMedGoogle Scholar
  105. 105.
    Palau F, Löfgren A, De Jonghe P, Bort S, Nelis E, Sevilla T, Martin J-J, Vílchez J, Prieto F, Van Broeckhoven C (1993) Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis. Hum Mol Genet 2:2031–2035PubMedGoogle Scholar
  106. 106.
    Pareek S, Notterpek L, Snipes GJ, Naef R, Sossin W, Laliberte J, Iacampo S, Suter U, Shooter EM, Murphy RA (1997) Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci 17:7754–7762PubMedGoogle Scholar
  107. 107.
    Pareek S, Suter U, Snipes GJ, Welcher AA, Shooter EM, Murphy RA (1993) Detection and processing of PMP22 in cultured Schwann cells. J Biol Chem 268:10372–10379PubMedGoogle Scholar
  108. 108.
    Pareyson D, Taroni F, Botti S, Morbin M, Baratta S, Lauria G, Ciano C, Sghirlanzoni A (2000) Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation. Neurology 54:1696–1698PubMedGoogle Scholar
  109. 109.
    Parkinson DB, Dickinson S, Bhaskaran A, Kinsella MT, Brophy PJ, Sherman DL, Sharghi-Namini S, Duran Alonso MB, Mirsky R, Jessen KR (2003) Regulation of the myelin gene periaxin provides evidence for Krox-20-independent myelin-related signalling in Schwann cells. Mol Cell Neurosci 23:13–27PubMedCrossRefGoogle Scholar
  110. 110.
    Parman Y, Plante-Bordeneuve V, Guiochon-Mantel A, Eraksoy M, Said G (1999) Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine-Sottas disease. Ann Neurol 45:518–522PubMedCrossRefGoogle Scholar
  111. 111.
    Patel PI, Franco B, Garcia C, Slaugenhaupt SA, Nakamura Y, Ledbetter DH, Chakravarti A, Lupski JR (1990) Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17. Am J Hum Genet 46:801–809PubMedGoogle Scholar
  112. 112.
    Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, Snipes GJ, Garcia CA, Francke U, Shooter EM, Lupski JR, Suter U (1992) The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nature Genet 1:159–165PubMedCrossRefGoogle Scholar
  113. 113.
    Pentao L, Wise CA, Chinault AC, Patel PI, Lupski JR (1992) Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nature Genet 2:292–300PubMedCrossRefGoogle Scholar
  114. 114.
    Phillips JP, Warner LE, Lupski JR, Garg BP (1999) Congenital hypomyelinating neuropathy: two patients with long-term follow-up. Pediatr Neurol 20:226–232PubMedCrossRefGoogle Scholar
  115. 115.
    Planté-Bordeneuve V, Guiochon-Mantel A, Lacroix C, Lapresle J, Said G (1999) The Roussy-Levy family: from the original description to the gene. Ann Neurol 46:770–773PubMedGoogle Scholar
  116. 116.
    Plante-Bordeneuve V, Parman Y, Guiochon-Mantel A, Alj Y, Deymeer F, Serdaroglu P, Eraksoy M, Said G (2001) The range of chronic demyelinating neuropathy of infancy: a clinico-pathological and genetic study of 15 unrelated cases. J Neurol 248:795–803PubMedGoogle Scholar
  117. 117.
    Potocki L, Chen KS, Koeuth T, Killian J, Iannaccone ST, Shapira SK, Kashork CD, Spikes AS, Shaffer LG, Lupski JR (1999) DNA rearrangements on both homologues of chromosome 17 in a mildly delayed individual with a family history of autosomal dominant carpal tunnel syndrome. Am J Hum Genet 64:471–478PubMedCrossRefGoogle Scholar
  118. 118.
    Previtali SC, Zerega B, Sherman DL, Brophy PJ, Dina G, King RH, Salih MM, Feltri L, Quattrini A, Ravazzolo R, Wrabetz L, Monaco AP, Bolino A (2003) Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve. Hum Mol Genet 12:1713–1723PubMedCrossRefGoogle Scholar
  119. 119.
    Quattrone A, Gambardella A, Bono F, Aguglia U, Bolino A, Bruni AC, Montesi MP, Oliveri RL, Sabatelli M, Tamburrini O, Valentino P, Van Broeckhoven C, Zappia M (1996) Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: Clinical, electrophysiologic, and genetic aspects of a large family. Neurology 46:1318–1324PubMedGoogle Scholar
  120. 120.
    Raeymaekers P, Timmerman V, De Jonghe P, Swerts L, Gheuens J, Martin J-J, Muylle L, De Winter G, Vandenberghe A, Van Broeckhoven C (1989) Localization of the mutation in an extended family with Charcot-Marie-Tooth neuropathy (HMSN I). Am J Hum Genet 45:953–958PubMedGoogle Scholar
  121. 121.
    Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin J-J, de Visser M, Bolhuis PA, Van Broeckhoven C, HMSN Collaborative Research Group (1991) Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type la (CMT 1a). Neuromusc Disord 1:93–97PubMedGoogle Scholar
  122. 122.
    Raeymaekers P, Timmerman V, Nelis E, Van Hul W, De Jonghe P, Martin J-J, Van Broeckhoven C, HMSN Collaborative Research Group (1992) Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). J Med Genet 29:5–11PubMedGoogle Scholar
  123. 123.
    Reiter LT, Hastings PJ, Nelis E, De Jonghe P, Van Broeckhoven C, Lupski JR (1998) Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients. Am J Hum Genet 62:1023–1033PubMedCrossRefGoogle Scholar
  124. 124.
    Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, Lupski JR (1996) A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nature Genet 12:288–297PubMedCrossRefGoogle Scholar
  125. 125.
    Roa BB, Garcia CA, Pentao L, Killian JM, Trask BJ, Suter U, Snipes GJ, Ortiz-Lopez R, Shooter EM, Patel PI, Lupski JR (1993) Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nature Genet 5:189–194PubMedGoogle Scholar
  126. 126.
    Rogers T, Chandler D, Angelicheva D, Thomas PK, Youl B, Tournev I, Gergelcheva V, Kalaydjieva L (2000) A novel locus for autosomal recessive peripheral neuropathy in the EGR2 region on 10q23. Am J Hum Genet 67:664–671PubMedCrossRefGoogle Scholar
  127. 127.
    Roussy G, Levy G (1926) Sept cas d’une maladie familiale particulière. Rev Neurol 1:427–450Google Scholar
  128. 128.
    Salinas AE, Wong MG (1999) Glutathione S-transferases — a review. Curr Med Chem 6:279–309PubMedGoogle Scholar
  129. 129.
    Sambuughin N, de Bantel A, McWilliams S, Sivakumar K (2003) Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene. Neurology 60:506–508PubMedGoogle Scholar
  130. 130.
    Sander S, Ouvrier RA, McLeod JG, Nicholson GA, Pollard JD (2000) Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry 68:483–488PubMedCrossRefGoogle Scholar
  131. 131.
    Schneider-Maunoury S, Topilko P, Seitandou T, Levi G, Cohen-Tannoudji M, Pournin S, Babinet C, Charnay P (1993) Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell 75:1199–1214PubMedCrossRefGoogle Scholar
  132. 132.
    Senderek J, Bergmann C, Ramaekers VT, Nelis E, Bernert G, Makowski A, Züchner S, De Jonghe P, Rudnik-Schöneborn S, Zerres K, Schröder JM (2003) Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. Brain 126:642–649PubMedCrossRefGoogle Scholar
  133. 133.
    Senderek J, Bergmann C, Stendel C, Kirfel J, Verpoorten N, De Jonghe P, Timmerman V, Chrast R, Verheijen MHG, Lemke G, Battaloglu E, Parman Y, Erdem S, Tan E, Topaloglu H, Hahn A, Müller-Felber W, Rizzuto N, Fabrizi GM, Stuhrmann M, Rudnik-Schöneborn S, Züchner S, Schröder JM, Buchheim E, Straub V, Klepper J, Huehne K, Rautenstrauss B, Büttner R, Nelis E, Zerres K (2003) Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet 73:1106–1119PubMedCrossRefGoogle Scholar
  134. 134.
    Senderek J, Bergmann C, Weber S, Ketelsen UP, Schorle H, Rudnik-Schöneborn S, Büttner R, Buchheim E, Zerres K (2003) Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 12:349–356PubMedCrossRefGoogle Scholar
  135. 135.
    Senderek J, Hermanns B, Lehmann U, Bergmann C, Marx G, Kabus C, Timmerman V, Stoltenburg-Didinger G, Schröder JM (2000) Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp 61Gly; Tyr119Cys) and a possible “hotspot” on Thr124Met. Brain Pathol 10:235–248PubMedGoogle Scholar
  136. 136.
    Senderek J, Ramaekers VT, Zerres K, Rudnik-Schöneborn S, Schröder JM, Bergmann C (2001) Phenotypic variation of a novel nonsense mutation in the P0 intracellular domain. J Neurol Sci 192:49–51PubMedCrossRefGoogle Scholar
  137. 137.
    Shapiro H, Doyle JP, Hensley P, Colman DR, Hendrickson WA (1996) Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17:435–449PubMedCrossRefGoogle Scholar
  138. 138.
    Shaw E, McCue LA, Lawrence CE, Dordick JS (2002) Identification of a novel class in the alpha/beta hydrolase fold superfamily: the N-myc differentiation-related proteins. Proteins 47:163–168PubMedCrossRefGoogle Scholar
  139. 1139.
    Simonati A, Fabrizi GM, Taioli F, Polo A, Cerini R, Rizzuto N (2002) Dejerine-Sottas neuropathy with multiple nerve roots enlargement and hypomyelination associated with a missense mutation of the transmembrane domain of MPZ/P0. J Neurol 249:1298–1302PubMedCrossRefGoogle Scholar
  140. 140.
    Snipes GJ, Suter U, Welcher AA, Shooter EM (1992) Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 117:225–238PubMedCrossRefGoogle Scholar
  141. 141.
    Spreyer P, Kuhn G, Hanemann CO, Gillen C, Schaal H, Kuhn R, Lemke G, Müller HW (1991) Axon-regulated expression of a Schwann cell transcript that is homologous to a ‘growth arrest-specific’ gene. EMBO J 10:3661–3668PubMedGoogle Scholar
  142. 142.
    Starr A, Michalewski HJ, Zeng FG, Fujikawa-Brooks S, Linthicum F, Kim CS, Winnier D, Keats B (2003) Pathology and physiology of auditory neuropathy with a novel mutation in the MPZ gene (Tyr145→Ser). Brain 126:1604–1619PubMedCrossRefGoogle Scholar
  143. 143.
    Street VA, Bennett CL, Goldy JD, Shirk AJ, Kleopa KA, Tempel BL, Lipe HP, Scherer SS, Bird TD, Chance PF (2003) Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 60:22–26PubMedGoogle Scholar
  144. 144.
    Street VA, Goldy JD, Golden AS, Tempel BL, Bird TD, Chance PF (2002) Mapping of Charcot-Marie-Tooth disease type 1C to chromosome 16p identifies a novel locus for demyelinating neuropathies. Am J Hum Genet 70:244–250PubMedCrossRefGoogle Scholar
  145. 145.
    Suter U, Snipes J, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM, Patel PI (1994) Regulation of tissue-specific expression of alternative Peripheral Myelin Protein-22 (PMP22) gene transcripts by two promotors. J Biol Chem 269:25795–25808PubMedGoogle Scholar
  146. 146.
    Swiatek PJ, Gridley T (1993) Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox-20. Genes Dev 7:2071–2084PubMedGoogle Scholar
  147. 147.
    Swirnoff AH, Milbrandt J (1995) DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol Cell Biol 15:2275–2287PubMedGoogle Scholar
  148. 148.
    Takashima H, Boerkoel CF, De Jonghe P, Ceuterick C, Martin JJ, Voit T, Schröder JM, Williams A, Brophy PJ, Timmerman V, Lupski JR (2002) Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 51:709–715PubMedCrossRefGoogle Scholar
  149. 149.
    Thomas PK, Kalaydjieva L, Youl B, Rogers T, Angelicheva D, King RH, Guergueltcheva V, Colomer J, Lupu C, Corches A, Popa G, Merlini L, Shmarov A, Muddle JR, Nourallah M, Tournev I (2001) Hereditary motor and sensory neuropathy-russe: new autosomal recessive neuropathy in Balkan Gypsies. Ann Neurol 50:452–457PubMedCrossRefGoogle Scholar
  150. 150.
    Thomas PK, King RH, Small JR, Robertson AM (1996) The pathology of Charcot-Marie-Tooth disease and related disorders. Neuropathol Appl Neurobiol 22:269–284PubMedCrossRefGoogle Scholar
  151. 151.
    Thomas PK, King RHM, Small JR, Robertson AM (1996) The pathology of Charcot-Marie-Tooth disease and related disorders. Neuropathol Appl Neurobiol 22:269–284PubMedGoogle Scholar
  152. 152.
    Thomas PK, Marques W Jr, Davis MB, Sweeney MG, King RH, Bradley JL, Muddle JR, Tyson J, Malcolm S, Harding AE (1997) The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120:465–478PubMedCrossRefGoogle Scholar
  153. 153.
    Timmerman V, De Jonghe P, Ceuterick C, De Vriendt E, Löfgren A, Nelis E, Warner LE, Lupski JR, Martin J-J, Van Broeckhoven C (1999) Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology 52:1827–1832PubMedGoogle Scholar
  154. 154.
    Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, Ben Othman K, Cullen B, Leach RJ, Hanemann CO, De Jonghe P, Raeymaekers P, van Ommen G-JB, Martin J-J, Müller HW, Vance JM, Fischbeck KH, Van Broeckhoven C (1992) The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nature Genet 1:171–175PubMedCrossRefGoogle Scholar
  155. 155.
    Timmerman V, Raeymaekers P, De Jonghe P, De Winter G, Swerts L, Jacobs K, Gheuens J, Martin J-J, Vandenberghe A, Van Broeckhoven C (1990) Assignment of the Charcot-Marie-Tooth neuropathy type 1 (CMT 1a) gene to 17p11.2-p12. Am J Hum Genet 47:680–685PubMedGoogle Scholar
  156. 156.
    Timmerman V, Rautenstrauss B, Reiter LT, Koeuth T, Löfgren A, Liehr T, Nelis E, Bathke KD, De Jonghe P, Grehl H, Martin J-J, Lupski JR, Van Broeckhoven C (1997) Detection of the CMT1A/HNPP recombination “hotspot” in unrelated patients of European descent. J Med Genet 34:43–49PubMedCrossRefGoogle Scholar
  157. 157.
    Timmins J, Schoehn G, Ricard-Blum S, Scianimanico S, Vernet T, Ruigrok RW, Weissenhorn W (2003) Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol 326:493–502PubMedCrossRefGoogle Scholar
  158. 158.
    Tooth HH (1886) The peroneal type of progressive muscular atrophy. HK Lewis, LondonGoogle Scholar
  159. 159.
    Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi ABY, Seltanidou T, Babinet C, Charnay P (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371:796–799PubMedCrossRefGoogle Scholar
  160. 160.
    Tournev I, Kalaydjieva L, Youl B, Ishpekova B, Guergueltcheva V, Kamenov O, Katzarova M, Kamenov Z, Raicheva-Terzieva M, King RH, Romanski K, Petkov R, Schmarov A, Dimitrova G, Popova N, Uzunova M, Milanov S, Petrova J, Petkov Y, Kolarov G, Aneva L, Radeva O, Thomas PK (1999) Congenital cataracts facial dysmorphism neuropathy syndrome, a novel complex genetic disease in Balkan Gypsies: clinical and electrophysiological observations. Ann Neurol 45:742–750PubMedCrossRefGoogle Scholar
  161. 161.
    Valentijn LJ, Baas F, Zorn I, Hensels GW, de Visser M, Bolhuis PA (1993) Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 2:2143–2146PubMedGoogle Scholar
  162. 162.
    Valentijn LJ, Bolhuis PA, Zorn I, Hoogendijk JE, van den Bosch N, Hensels GW, Stanton V, Jr, Housman DE, Fischbeck KH, Ross DA, Nicholson GA, Meershoek EJ, Dauwerse HG, van Ommen G-JB, Baas F (1992) The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nature Genet 1:166–170PubMedCrossRefGoogle Scholar
  163. 163.
    Vallat J-M, Sindou P, Preux P-M, Tabaraud F, Milor AM, Couratier P, LeGuern E, Brice A (1996) Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 39:813–817PubMedCrossRefGoogle Scholar
  164. 164.
    Vance JM, Nicholson GA, Yamaoka LH, Stajich J, Stewart JS, Speer MC, Hung W-J, Roses AD, Barker D, Pericak-Vance MA (1989) Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp Neurol 104:186–189PubMedCrossRefGoogle Scholar
  165. 165.
    Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodny EH, Karpati G, Watters GV, Nelis E, Van Broeckhoven C, Lupski JR (1996) Clinical phenotypes of different MPZ (Po) mutations may include Charcot-Marie-Tooth 1B, Dejerine-Sottas and congenital hypomyelination. Neuron 17:451–460PubMedCrossRefGoogle Scholar
  166. 166.
    Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob G, Lupski JR (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nature Genet 18:382–384PubMedCrossRefGoogle Scholar
  167. 167.
    Warner LE, Svaren J, Milbrandt J, Lupski JR (1999) Functional consequences of mutations in the early growth response 2 (EGR2) gene correlate with severity of human myelinopathies. Hum Mol Genet 8:1245–1251PubMedCrossRefGoogle Scholar
  168. 168.
    Williams AC, Brophy PJ (2002) The function of the Periaxin gene during nerve repair in a model of CMT4F. J Anat 200:323–330PubMedCrossRefGoogle Scholar
  169. 169.
    Windebank AJ (1993) Inherited recurrent focal neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral Neuropathy. W.B. Saunders Company, Philadelphia, pp 1137–1148Google Scholar
  170. 170.
    Winter WC, Juel VC (2003) Hypoglossal neuropathy in hereditary neuropathy with liability to pressure palsy. Neurology 61:1154–1155PubMedGoogle Scholar
  171. 171.
    Wise CA, Garcia CA, Davis SN, Heju Z, Pentao L, Patel PI, Lupski JR (1993) Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am J Hum Genet 53:853–863PubMedGoogle Scholar
  172. 172.
    Wulf P, Bernhardt RR, Suter U (1999) Characterization of peripheral myelin protein 22 in zebrafish (zPMP22) suggests an early role in the development of the peripheral nervous system. J Neurosci Res 57:467–478PubMedCrossRefGoogle Scholar
  173. 173.
    Xu W, Shy M, Kamholz J, Elferink L, Xu G, Lilien J, Balsamo J (2001) Mutations in the cytoplasmic domain of PO reveal a role for PKC-mediated phosphorylation in adhesion and myelination. J Cell Biol 155:439–446PubMedCrossRefGoogle Scholar
  174. 174.
    Yamamoto M, Yasuda T, Hayasaka K, Ohnishi A, Yoshikawa H, Yanagihara T, Ikegami T, Yamamoto T, Ohashi H, Nishimura T, Mitsuma T, Kiyosawa H, Chance PF, Sobue G (1997) Locations of crossover breakpoints within the CMT1A-REP repeat in Japanese patients with CMT1A and HNPP. Hum Genet 99:151–154PubMedCrossRefGoogle Scholar
  175. 175.
    Yener GG, Guiochon-Mantel A, Obuz F, Baklan B, Ozturk V, Kovanlikaya I, Cakmur R, Genc A (2001) Phe 84 deletion of the PMP22 gene associated with hereditary motor and sensory neuropathy HMSN III with multiple cranial neuropathy: clinical, neurophysiological and magnetic resonance imaging findings. J Neurol 248:193–196PubMedCrossRefGoogle Scholar
  176. 176.
    Yin X, Kidd GJ, Wrabetz L, Feltri ML, Messing A, Trapp BD (2000) Schwann cell myelination requires timely and precise targeting of P(0) protein. J Cell Biol 148:1009–1020PubMedCrossRefGoogle Scholar
  177. 177.
    Yoshihara T, Kanda F, Yamamoto M, Ishihara H, Misu K, Hattori N, Chihara K, Sobue G (2001) A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot-Marie-Tooth disease type 1. J Neurol Sci 184:149–153PubMedCrossRefGoogle Scholar
  178. 178.
    Young P, Grote K, Kuhlenbäumer G, Debus O, Kurlemann H, Halfter H, Funke H, Ringelstein EB, Stogbauer F (2001) Mutation analysis in Chariot-Marie-Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity. J Neurol 248:410–415PubMedCrossRefGoogle Scholar
  179. 179.
    Young P, Stogbauer F, Eller B, De Jonghe P, Löfgren A, Timmerman V, Rautenstrauss B, Oexle K, Grehl H, Kuhlenbäumer G, Van Broeckhoven C, Ringelstein EB, Funke H (2000) PMP22 Thr118Met is not a clinically relevant CMT1 marker. J Neurol 247:696–700PubMedCrossRefGoogle Scholar
  180. 180.
    Zhu Q, Couillard-Després S, Julien J-P (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol 148:299–316PubMedCrossRefGoogle Scholar
  181. 181.
    Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G (1996) The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 8:129–145CrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2005

Authors and Affiliations

  • E. Nelis
  • P. De Jonghe
  • V. Timmerman

There are no affiliations available

Personalised recommendations